BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 29784036)

  • 21. Longterm prognosis after hepatic resection for small hepatocellular carcinoma.
    Shimozawa N; Hanazaki K
    J Am Coll Surg; 2004 Mar; 198(3):356-65. PubMed ID: 14992736
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Statin use is associated with a lower risk of recurrence after curative resection in BCLC stage 0-A hepatocellular carcinoma.
    Yang SY; Wang CC; Chen KD; Liu YW; Lin CC; Chuang CH; Tsai YC; Yao CC; Yen YH; Hsiao CC; Hu TH; Tsai MC
    BMC Cancer; 2021 Jan; 21(1):70. PubMed ID: 33446127
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Liver resection of hepatocellular carcinoma within and beyond the Barcelona Clinic Liver Cancer guideline recommendations: Results from a high-volume liver surgery center in East Asia.
    Liu YW; Yong CC; Lin CC; Wang CC; Chen CL; Cheng YF; Wang JH; Yen YH; Chen CH
    J Surg Oncol; 2020 Dec; 122(8):1587-1594. PubMed ID: 32815189
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tenofovir Versus Entecavir on Recurrence of Hepatitis B Virus-Related Hepatocellular Carcinoma After Surgical Resection.
    Choi J; Jo C; Lim YS
    Hepatology; 2021 Feb; 73(2):661-673. PubMed ID: 32324905
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Radiofrequency ablation versus resection for the treatment of early stage hepatocellular carcinoma: a multicenter Australian study.
    Gory I; Fink M; Bell S; Gow P; Nicoll A; Knight V; Dev A; Rode A; Bailey M; Cheung W; Kemp W; Roberts SK;
    Scand J Gastroenterol; 2015 May; 50(5):567-76. PubMed ID: 25615260
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Benefit of Treating Hepatocellular Carcinoma Recurrence after Liver Transplantation and Analysis of Prognostic Factors for Survival in a Large Euro-American Series.
    Sapisochin G; Goldaracena N; Astete S; Laurence JM; Davidson D; Rafael E; Castells L; Sandroussi C; Bilbao I; Dopazo C; Grant DR; Lázaro JL; Caralt M; Ghanekar A; McGilvray ID; Lilly L; Cattral MS; Selzner M; Charco R; Greig PD
    Ann Surg Oncol; 2015 Jul; 22(7):2286-94. PubMed ID: 25472651
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preoperative inflammation-based markers predict early and late recurrence of hepatocellular carcinoma after curative hepatectomy.
    Liu Y; Wang ZX; Cao Y; Zhang G; Chen WB; Jiang CP
    Hepatobiliary Pancreat Dis Int; 2016 Jun; 15(3):266-74. PubMed ID: 27298102
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intrahepatic recurrence after curative resection of hepatocellular carcinoma: long-term results of treatment and prognostic factors.
    Poon RT; Fan ST; Lo CM; Liu CL; Wong J
    Ann Surg; 1999 Feb; 229(2):216-22. PubMed ID: 10024103
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of surgical resection for multiple hepatocellular carcinomas.
    Choi SH; Choi GH; Kim SU; Park JY; Joo DJ; Ju MK; Kim MS; Choi JS; Han KH; Kim SI
    World J Gastroenterol; 2013 Jan; 19(3):366-74. PubMed ID: 23372359
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prediction of recurrence and prognosis in patients with hepatocellular carcinoma after resection by use of CLIP score.
    Zhao WH; Ma ZM; Zhou XR; Feng YZ; Fang BS
    World J Gastroenterol; 2002 Apr; 8(2):237-42. PubMed ID: 11925599
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinicopathological features of recurrence in patients after 10-year disease-free survival following curative hepatic resection of hepatocellular carcinoma.
    Kaibori M; Kubo S; Nagano H; Hayashi M; Haji S; Nakai T; Ishizaki M; Matsui K; Uenishi T; Takemura S; Wada H; Marubashi S; Komeda K; Hirokawa F; Nakata Y; Uchiyama K; Kwon AH
    World J Surg; 2013 Apr; 37(4):820-8. PubMed ID: 23340708
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recurrence after liver resection for hepatocellular carcinoma: risk factors, treatment, and outcomes.
    Shah SA; Cleary SP; Wei AC; Yang I; Taylor BR; Hemming AW; Langer B; Grant DR; Greig PD; Gallinger S
    Surgery; 2007 Mar; 141(3):330-9. PubMed ID: 17349844
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Laparoscopic liver resection: 5-year experience at a single center.
    Long TC; Bac NH; Thuan ND; Dat le T; Viet DQ; Chuong le CH
    Surg Endosc; 2014 Mar; 28(3):796-802. PubMed ID: 24196550
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Surgical resection versus ablation for hepatocellular carcinoma ≤ 3 cm: a population-based analysis.
    Miura JT; Johnston FM; Tsai S; Eastwood D; Banerjee A; Christians KK; Turaga KK; Gamblin TC
    HPB (Oxford); 2015 Oct; 17(10):896-901. PubMed ID: 26228076
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Selection criteria for hepatic resection in intermediate-stage (BCLC stage B) multiple hepatocellular carcinoma.
    Wada H; Eguchi H; Noda T; Ogawa H; Yamada D; Tomimaru Y; Tomokuni A; Asaoka T; Kawamoto K; Gotoh K; Marubashi S; Umeshita K; Nagano H; Doki Y; Mori M
    Surgery; 2016 Nov; 160(5):1227-1235. PubMed ID: 27395761
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High expression of micro RNA-135A in hepatocellular carcinoma is associated with recurrence within 12 months after resection.
    von Felden J; Heim D; Schulze K; Krech T; Ewald F; Nashan B; Lohse AW; Wege H
    BMC Cancer; 2017 Jan; 17(1):60. PubMed ID: 28100188
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Outcomes after hepatic resection and subsequent multimodal treatment of recurrence for multifocal hepatocellular carcinoma.
    Kim PT; Jang JH; Atenafu EG; Fischer S; Greig PD; McGilvray ID; Wei AC; Gallinger S; Cleary SP
    Br J Surg; 2013 Oct; 100(11):1516-22. PubMed ID: 24037575
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Appropriate treatment strategies for intrahepatic recurrence after curative resection of hepatocellular carcinoma initially within the Milan criteria: according to the recurrence pattern.
    Zhang X; Li C; Wen T; Yan L; Li B; Yang J; Wang W; Xu M; Lu W; Jiang L
    Eur J Gastroenterol Hepatol; 2015 Aug; 27(8):933-40. PubMed ID: 25933127
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aspirin is associated with low recurrent risk in hepatitis B virus-related hepatocellular carcinoma patients after curative resection.
    Young SH; Chau GY; Lee IC; Yeh YC; Chao Y; Huo TI; Su CW; Lin HC; Hou MC; Lee MH; Huang YH
    J Formos Med Assoc; 2020 Jan; 119(1 Pt 2):218-229. PubMed ID: 31104872
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term survival of patients undergoing liver resection for very large hepatocellular carcinomas.
    Chang YJ; Chung KP; Chang YJ; Chen LJ
    Br J Surg; 2016 Oct; 103(11):1513-20. PubMed ID: 27550624
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.